Welcome to Cumberland Pharmaceuticals
Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company whose mission is to acquire currently marketed and late-stage development pharmaceutical products and grow them through marketing to targeted, underserved physician segments. Cumberland is dedicated to providing high quality products which address unmet medical needs.
The strategy for achieving these goals is comprised of five key components: rigorous product selection, innovative financing, focused marketing, efficient operations and access to a long-term product pipeline.
Cumberland is committed to delivering exceptional products that have undergone a multi-disciplinary analysis and evaluation. Target markets include hospital acute care and gastroenterology. Products which demonstrate safety and efficacy as well as competitive advantage represent ideal candidates. more...
Recent Announcements
June 11, 2009
Cumberland Pharmaceuticals Announces FDA Approval of Caldolor™
May 18, 2009
Cumberland Pharmaceuticals Provides Hospital In-Service Webcast for Acetadote®
Jan 13, 2009
Cumberland Pharmaceuticals Appoints Lee Product Director
Dec 18, 2008
Cumberland Pharmaceuticals Reports FDA Approval for Updated Labeling of Acetadote®
Medical Information
This website is not for medical emergencies. Do not use this website for Adverse Event Reporting. If you are a patient, caregiver or healthcare professional and need product related information, please visit our Products page, which will link you to product-specific websites.